These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39154863)

  • 1. Management of patellar and trochlear cartilage lesions with matrix-induced autologous chondrocyte implantation in conjunction with patellofemoral realignment procedures improves patient-reported outcomes and magnetic resonance image appearance.
    Retzky JS; Carey EG; Selley RS; Fletcher C; Hartwell MJ; Burge AJ; Gomoll A; Strickland S
    J ISAKOS; 2024 Oct; 9(5):100311. PubMed ID: 39154863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Radiological Outcomes at ≥10-Year Follow-up After Matrix-induced Autologous Chondrocyte Implantation in the Patellofemoral Joint.
    Ebert JR; Klinken S; Fallon M; Wood DJ; Janes GC
    Am J Sports Med; 2024 Aug; 52(10):2532-2540. PubMed ID: 39101611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of 2-Year Outcomes in Patients Undergoing Tibiofemoral or Patellofemoral Matrix-Induced Autologous Chondrocyte Implantation.
    Ebert JR; Schneider A; Fallon M; Wood DJ; Janes GC
    Am J Sports Med; 2017 Dec; 45(14):3243-3253. PubMed ID: 28910133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective clinical and radiologic evaluation of patellofemoral matrix-induced autologous chondrocyte implantation.
    Ebert JR; Fallon M; Smith A; Janes GC; Wood DJ
    Am J Sports Med; 2015 Jun; 43(6):1362-72. PubMed ID: 25784629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) Scores > 55 at 6 Months Postoperative Predict Ability to Achieve Patient Acceptable Symptomatic State at Minimum 1 Year Postoperative Following Autologous Chondrocyte Implantation for Grade IV Chondral Defects About the Patellofemoral Joint.
    Retzky JS; Fletcher C; Rizy M; Burge A; Strickland SM
    Cartilage; 2024 Apr; ():19476035241244491. PubMed ID: 38613220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cartilage defects in the patellofemoral joint with matrix-associated autologous chondrocyte implantation effectively improves pain, function, and radiological outcomes after 5-7 years.
    Eichinger M; Henninger B; Petry B; Schuster P; Herbst E; Wagner M; Rosenberger R; Mayr R
    Arch Orthop Trauma Surg; 2024 Apr; 144(4):1655-1665. PubMed ID: 38206448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10-Year Prospective Clinical and Radiological Evaluation After Matrix-Induced Autologous Chondrocyte Implantation and Comparison of Tibiofemoral and Patellofemoral Graft Outcomes.
    Ebert JR; Zheng M; Fallon M; Wood DJ; Janes GC
    Am J Sports Med; 2024 Mar; 52(4):977-986. PubMed ID: 38384192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix-induced autologous chondrocyte implantation (MACI) for chondral defects in the patellofemoral joint.
    Meyerkort D; Ebert JR; Ackland TR; Robertson WB; Fallon M; Zheng MH; Wood DJ
    Knee Surg Sports Traumatol Arthrosc; 2014 Oct; 22(10):2522-30. PubMed ID: 24817164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Surface Cartilage Defects about the Knee Treated with Cartilage Restoration Procedures Show Good Outcomes and Survivorship at Minimum 2-Year Follow-Up.
    Retzky JS; Palhares GM; Rizy M; Hinkley P; Gomoll AH; Strickland SM
    Cartilage; 2024 Jun; 15(2):77-83. PubMed ID: 37853671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of "patellofemoral" cartilage lesions with matrix-assisted autologous chondrocyte transplantation: a comparison of patellar and trochlear lesions.
    Filardo G; Kon E; Andriolo L; Di Martino A; Zaffagnini S; Marcacci M
    Am J Sports Med; 2014 Mar; 42(3):626-34. PubMed ID: 24302700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Wiberg Patellar Type on Outcomes and Survival Following Cell-Based Cartilage Repair for Patellar Chondral Lesions at Midterm Follow-up.
    Retzky JS; Thacher RR; Palhares GH; Gomoll AH; Strickland SM
    Am J Sports Med; 2024 Mar; 52(3):705-709. PubMed ID: 38243799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous chondrocyte implantation and anteromedialization for isolated patellar articular cartilage lesions: 5- to 11-year follow-up.
    Gillogly SD; Arnold RM
    Am J Sports Med; 2014 Apr; 42(4):912-20. PubMed ID: 24519181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous Chondrocyte Implantation for Bipolar Chondral Lesions in the Patellofemoral Compartment: Clinical Outcomes at a Mean 9 Years' Follow-up.
    Ogura T; Bryant T; Merkely G; Minas T
    Am J Sports Med; 2019 Mar; 47(4):837-846. PubMed ID: 30758979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-Assisted Autologous Chondrocyte Transplantation for the Treatment of Patellofemoral Chondral Lesions: Long-term Results at a Minimum 15-Year Follow-up.
    Boffa A; Andriolo L; Angelelli L; Pizzuti V; Filardo G; Zaffagnini S; Di Martino A
    Am J Sports Med; 2024 Jul; 52(9):2222-2229. PubMed ID: 39101726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined MPFL Reconstruction with Tibial Tubercle Osteotomy and Repair of Patellar Cartilage Defect with Particulated Juvenile Articular Cartilage.
    Dennis ER; Marmor WA; Shubin Stein BE
    JBJS Essent Surg Tech; 2022; 12(4):e21.00013. PubMed ID: 36743281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid- to Long-Term Clinical Outcomes of Cartilage Restoration of Knee Joint with Allogenic Next-Generation Matrix-Induced Autologous Chondrocyte Implantation (MACI).
    Liu Y; Ma N; Zhao Z; Guo Q
    Orthop Surg; 2023 Feb; 15(2):549-562. PubMed ID: 36650102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations and treatment outcomes for patellofemoral articular cartilage defects with autologous chondrocyte implantation: prospective evaluation at average 4-year follow-up.
    Pascual-Garrido C; Slabaugh MA; L'Heureux DR; Friel NA; Cole BJ
    Am J Sports Med; 2009 Nov; 37 Suppl 1():33S-41S. PubMed ID: 19861699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Long-term Follow-up of Autologous Chondrocyte Implantation With Periosteum Versus Matrix-Associated Autologous Chondrocyte Implantation: A Randomized Clinical Trial.
    Barié A; Kruck P; Sorbi R; Rehnitz C; Oberle D; Walker T; Zeifang F; Moradi B
    Am J Sports Med; 2020 Jul; 48(9):2230-2241. PubMed ID: 32667270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loose Body Versus Trochlear Biopsy Matrix-Induced Autologous Chondrocyte Implantation (MACI) MOCART Scores and IKDC Reported Outcomes in Pediatric Patients.
    Hill Z; Delman C; Shelton T; Vander Voort W; Haus B
    J Pediatr Orthop; 2023 Jan; 43(1):e25-e29. PubMed ID: 36253889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patellofemoral Cartilage Lesions Treated With Particulated Juvenile Allograft Cartilage: A Prospective Study With Minimum 2-Year Clinical and Magnetic Resonance Imaging Outcomes.
    Wang T; Belkin NS; Burge AJ; Chang B; Pais M; Mahony G; Williams RJ
    Arthroscopy; 2018 May; 34(5):1498-1505. PubMed ID: 29395552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.